130 related articles for article (PubMed ID: 11301391)
1. Duration of symptoms prior to diagnosis is related inversely to presenting disease stage in children with medulloblastoma.
Halperin EC; Watson DM; George SL
Cancer; 2001 Apr; 91(8):1444-50. PubMed ID: 11301391
[TBL] [Abstract][Full Text] [Related]
2. Is there a correlation between duration of presenting symptoms and stage of medulloblastoma at the time of diagnosis?
Halperin EC; Friedman HS
Cancer; 1996 Aug; 78(4):874-80. PubMed ID: 8756384
[TBL] [Abstract][Full Text] [Related]
3. Childhood medulloblastoma in northwest England 1954 to 1997: incidence and survival.
Alston RD; Newton R; Kelsey A; Newbould MJ; Birch JM; Lawson B; McNally RJ
Dev Med Child Neurol; 2003 May; 45(5):308-14. PubMed ID: 12729144
[TBL] [Abstract][Full Text] [Related]
4. A long duration of the prediagnostic symptomatic interval is not associated with an unfavourable prognosis in childhood medulloblastoma.
Gerber NU; von Hoff K; von Bueren AO; Treulieb W; Deinlein F; Benesch M; Zwiener I; Soerensen N; Warmuth-Metz M; Pietsch T; Mittler U; Kuehl J; Kortmann RD; Grotzer MA; Rutkowski S
Eur J Cancer; 2012 Sep; 48(13):2028-36. PubMed ID: 22153558
[TBL] [Abstract][Full Text] [Related]
5. Your diagnosis? A 12-year-old girl with latent tuberculosis presenting with nausea, vomiting and increasing frontal headache.
De Gaudio M; Chiappini E; Catania P; Mussa F; Galli L; de Martino M
Eur J Pediatr; 2009 Feb; 168(2):245-6. PubMed ID: 18797925
[TBL] [Abstract][Full Text] [Related]
6. Metastasis stage, adjuvant treatment, and residual tumor are prognostic factors for medulloblastoma in children: conclusions from the Children's Cancer Group 921 randomized phase III study.
Zeltzer PM; Boyett JM; Finlay JL; Albright AL; Rorke LB; Milstein JM; Allen JC; Stevens KR; Stanley P; Li H; Wisoff JH; Geyer JR; McGuire-Cullen P; Stehbens JA; Shurin SB; Packer RJ
J Clin Oncol; 1999 Mar; 17(3):832-45. PubMed ID: 10071274
[TBL] [Abstract][Full Text] [Related]
7. Survival and prognostic factors in a series of adults with medulloblastomas.
Riffaud L; Saikali S; Leray E; Hamlat A; Haegelen C; Vauleon E; Lesimple T
J Neurosurg; 2009 Sep; 111(3):478-87. PubMed ID: 19231932
[TBL] [Abstract][Full Text] [Related]
8. Medulloblastoma: recent advances and directions in diagnosis and management--Part I.
Chin HW; Maruyama Y; Young AB
Curr Probl Cancer; 1984 May; 8(11):4-54. PubMed ID: 6383718
[No Abstract] [Full Text] [Related]
9. Local control in non-metastatic medulloblastoma.
Christopherson KM; Bradley JA; Rotondo RL; Pincus DW; Fort JA; Morris CG; Mendenhall NP; Marcus RB; Indelicato DJ
Acta Oncol; 2014 Sep; 53(9):1151-7. PubMed ID: 24991891
[TBL] [Abstract][Full Text] [Related]
10. Signs and symptoms of patients with brain tumors presenting to the emergency department.
Snyder H; Robinson K; Shah D; Brennan R; Handrigan M
J Emerg Med; 1993; 11(3):253-8. PubMed ID: 8340578
[TBL] [Abstract][Full Text] [Related]
11. Adult medulloblastoma: prognostic factors and patterns of relapse.
Chan AW; Tarbell NJ; Black PM; Louis DN; Frosch MP; Ancukiewicz M; Chapman P; Loeffler JS
Neurosurgery; 2000 Sep; 47(3):623-31; discussion 631-2. PubMed ID: 10981749
[TBL] [Abstract][Full Text] [Related]
12. Meningeal signs as the presenting feature of medulloblastoma.
Pollono DG; Tomarchio S; Drut R; Jones M; Ripoli MC; Fortuni ME
Med Pediatr Oncol; 1999 Jun; 32(6):477-8. PubMed ID: 10358718
[No Abstract] [Full Text] [Related]
13. Medulloblastoma in childhood: Impact of radiation technique upon the outcome of treatment.
Chojnacka M; SkowroĊska-Gardas A
Pediatr Blood Cancer; 2004 Feb; 42(2):155-60. PubMed ID: 14752880
[TBL] [Abstract][Full Text] [Related]
14. Misdiagnosing recurrent medulloblastoma: the danger of examination and imaging without histological confirmation.
Weintraub L; Miller T; Friedman I; Abbott R; Levy AS
J Neurosurg Pediatr; 2014 Jan; 13(1):33-7. PubMed ID: 24206345
[TBL] [Abstract][Full Text] [Related]
15. Prognostic factors in medulloblastoma, including DNA ploidy.
Zerbini C; Gelber RD; Weinberg D; Sallan SE; Barnes P; Kupsky W; Scott RM; Tarbell NJ
J Clin Oncol; 1993 Apr; 11(4):616-22. PubMed ID: 8478656
[TBL] [Abstract][Full Text] [Related]
16. Time to diagnosis of brain tumors in children: a single-centre experience.
Molineus A; Boxberger N; Redlich A; Vorwerk P
Pediatr Int; 2013 Jun; 55(3):305-9. PubMed ID: 23480630
[TBL] [Abstract][Full Text] [Related]
17. Effects of medulloblastoma resections on outcome in children: a report from the Children's Cancer Group.
Albright AL; Wisoff JH; Zeltzer PM; Boyett JM; Rorke LB; Stanley P
Neurosurgery; 1996 Feb; 38(2):265-71. PubMed ID: 8869053
[TBL] [Abstract][Full Text] [Related]
18. Duration of the pre-diagnostic interval in medulloblastoma is subgroup dependent.
Ramaswamy V; Remke M; Shih D; Wang X; Northcott PA; Faria CC; Raybaud C; Tabori U; Hawkins C; Rutka J; Taylor MD; Bouffet E
Pediatr Blood Cancer; 2014 Jul; 61(7):1190-4. PubMed ID: 24616042
[TBL] [Abstract][Full Text] [Related]
19. Surveillance imaging in children with medulloblastoma (posterior fossa PNET).
Roebuck DJ; Villablanca JG; Maher K; Nelson MD
Pediatr Radiol; 2000 Jul; 30(7):447-50. PubMed ID: 10929362
[TBL] [Abstract][Full Text] [Related]
20. Interval between onset of symptoms and diagnosis of medulloblastoma in children: distribution and determinants in a population-based study.
Brasme JF; Chalumeau M; Doz F; Lacour B; Valteau-Couanet D; Gaillard S; Delalande O; Aghakhani N; Sainte-Rose C; Puget S; Grill J
Eur J Pediatr; 2012 Jan; 171(1):25-32. PubMed ID: 21537925
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
